CA2537757A1 - The combination of a serotonin reuptake inhibitor and amoxapine - Google Patents

The combination of a serotonin reuptake inhibitor and amoxapine Download PDF

Info

Publication number
CA2537757A1
CA2537757A1 CA002537757A CA2537757A CA2537757A1 CA 2537757 A1 CA2537757 A1 CA 2537757A1 CA 002537757 A CA002537757 A CA 002537757A CA 2537757 A CA2537757 A CA 2537757A CA 2537757 A1 CA2537757 A1 CA 2537757A1
Authority
CA
Canada
Prior art keywords
serotonin
reuptake inhibitor
serotonin reuptake
compound
amoxapine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002537757A
Other languages
English (en)
French (fr)
Inventor
Thomas Ivo Franciscus Hubert Cremers
Sandra Hogg Willigers
Joern Arnt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
H Lundbeck AS
Original Assignee
H. Lundbeck A/S
Thomas Ivo Franciscus Hubert Cremers
Sandra Hogg Willigers
Joern Arnt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H. Lundbeck A/S, Thomas Ivo Franciscus Hubert Cremers, Sandra Hogg Willigers, Joern Arnt filed Critical H. Lundbeck A/S
Priority claimed from PCT/DK2004/000580 external-priority patent/WO2005023266A1/en
Publication of CA2537757A1 publication Critical patent/CA2537757A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002537757A 2003-09-04 2004-09-01 The combination of a serotonin reuptake inhibitor and amoxapine Abandoned CA2537757A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200301269 2003-09-04
DKPA200301269 2003-09-04
PCT/DK2004/000580 WO2005023266A1 (en) 2003-09-04 2004-09-01 The combination of a serotonin reuptake inhibitor and amoxapine

Publications (1)

Publication Number Publication Date
CA2537757A1 true CA2537757A1 (en) 2005-03-17

Family

ID=36319901

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002537757A Abandoned CA2537757A1 (en) 2003-09-04 2004-09-01 The combination of a serotonin reuptake inhibitor and amoxapine

Country Status (6)

Country Link
KR (1) KR20060072126A (ko)
CN (1) CN1845744A (ko)
CA (1) CA2537757A1 (ko)
EA (1) EA200600534A1 (ko)
IS (1) IS8299A (ko)
ZA (1) ZA200601463B (ko)

Also Published As

Publication number Publication date
IS8299A (is) 2006-02-13
ZA200601463B (en) 2007-05-30
EA200600534A1 (ru) 2006-08-25
KR20060072126A (ko) 2006-06-27
CN1845744A (zh) 2006-10-11

Similar Documents

Publication Publication Date Title
US20100267772A1 (en) Combination of a Serotonin Reuptake Inhibitor and Agomelatine
EP2145620A2 (en) Gaboxadol for treating depression and other affective disorders
US20050234093A1 (en) Treatment of depression and other affective disorders
EP1545552B1 (en) Combination therapy wherein a serotonin reuptake inhibitor is used
CA2537747A1 (en) The combination of a serotonin reuptake inhibitor and loxapine
US20070042014A1 (en) Combination of a serotonin reuptake inhibitor and loxapine
US20060223857A1 (en) Combination of a serotonin reuptake inhibitor and a glycine transporter type 1 inhibitor for the treatment of depression
EP1696896A2 (en) The combination of a serotonin reuptake inhibitor and a histamine 3 receptor antagonist, inverse agonist or partial agonist
US20070066601A1 (en) Combination of a serotonin reuptake inhibitor and a histamine 3 receptor antagonist, inverse agonist or partial agonist
US20080167290A1 (en) Combination of a Serotonin Reuptake Inhibitor and Amoxapine
CA2537757A1 (en) The combination of a serotonin reuptake inhibitor and amoxapine
ZA200509588B (en) The combination of a serotonin reuptake inhibitors and agomelatine
CA2579520A1 (en) Combination therapy wherein a serotonin reuptake inhibitor is used
MXPA06005127A (en) The combination of a serotonin reuptake inhibitor and a histamine 3 receptor antagonist, inverse agonist or partial agonist
ZA200409278B (en) Combination therapy wherein a serotonin reuptake inhibitor is used

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead